References

10.1136/gutjnl-2019-319766

10.1136/gutjnl-2019-319766 · External reference

Betterment of diclofenac-induced nephrotoxicity by pentoxifylline through modulation of inflammatory biomarkers

10.22159/ajpcr.2019.v12i3.30829 · 2019 · External reference

10.1016/b978-0-12-800141-7.00003-6

10.1016/b978-0-12-800141-7.00003-6 · External reference

Current insights toward kidney injury: Decrypting the dual role and mechanism involved of herbal drugs in inducing kidney injury and its treatment

10.1016/j.crbiot.2020.11.002 · 2020 · External reference

Nephrotoxins and nephrotoxic acute kidney injury

10.1007/s00467-019-04397-2 · 2020 · External reference

Hypertension in chronic kidney disease (CKD): Diagnosis, classification, and therapeutic targets

10.1093/ajh/hpaa209 · 2020 · External reference

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets

2021 · External reference

10.1038/s41572-021-00284-z

10.1038/s41572-021-00284-z · External reference

Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method

2021 · External reference

Unresolved reference

2022 · External reference

The use of nephrotoxic drugs in patients with chronic kidney disease

10.1007/s11096-019-00811-9 · 2019 · External reference

10.3389/fonc.2020.00779

10.3389/fonc.2020.00779 · External reference

Acute kidney injury in septic patients treated by selected nephrotoxic antibiotic agents—pathophysiology and biomarkers—A review

10.3390/ijms21197115 · 2020 · External reference

Drug-induced acute kidney injury: diverse mechanisms of tubular injury

2019 · External reference

Drug-Induced hospital-acquired acute kidney injury in China: A multicenter cross-sectional survey

10.1159/000510455 · 2021 · External reference

The 6R’s of drug induced nephrotoxicity

10.1186/s12882-017-0536-3 · 2017 · External reference

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

10.1007/s00134-015-3934-7 · 2015 · External reference

Current strategies in assessment of nanotoxicity: alternatives to in vivo animal testing

2021 · External reference

Curated data in — trustworthy in silico models out: the impact of data quality on the reliability of artificial intelligence models as alternatives to animal testing

10.1177/02611929211029635 · 2021 · External reference

Combining in silico tools with multicriteria analysis for alternatives assessment of hazardous chemicals: accounting for the transformation products of decaBDE and its alternatives

10.1021/acs.est.0c02593 · 2021 · External reference

Experimental approach to nasal septal cartilage regeneration with adipose tissue-derived stem cells and decellularized porcine septal cartilage

10.1111/xen.12660 · 2021 · External reference

10.1002/jimd.12319

10.1002/jimd.12319 · External reference

3D Bioprinting of neural tissues

10.1002/adhm.202001600 · 2021 · External reference

Amylomaltases in extremophilic microorganisms

10.3390/biom11091335 · 2021 · External reference

In silico prediction of toxicity and its applications for chemicals at work

10.1007/s13530-020-00056-4 · 2020 · External reference

Integrating in silico models and read-across methods for predicting toxicity of chemicals: A step-wise strategy

10.1016/j.envint.2019.105060 · 2019 · External reference

Prediction of oral pharmacokinetics using a combination of in silico descriptors and in vitro ADME properties

10.1021/acs.molpharmaceut.0c01009 · 2021 · External reference

Predicting the in vivo developmental toxicity of benzo[a]pyrene (BaP) in rats by an in vitro–in silico approach

10.1007/s00204-021-03128-7 · 2021 · External reference

10.1007/s11030-021-10217-3

10.1007/s11030-021-10217-3 · External reference

10.1016/j.isci.2021.103052

10.1016/j.isci.2021.103052 · External reference

10.1016/j.csbj.2021.01.012 · Admitted local publication

Quantitative structure-activity relationship (QSAR) studies on the toxic effects of nitroaromatic compounds (NACs): A systematic review

2021 · External reference

Synthesis, extracorporeal nephrotoxicity, and 3D-QSAR of andrographolide derivatives

10.1111/cbdd.13796 · 2021 · External reference

Human nephrotoxicity prediction models for three types of kidney injury based on data sets of pharmacological compounds and their metabolites

10.1021/tx400249t · 2013 · External reference

Development and validation of a machine learning model to predict near-term risk of iatrogenic hypoglycemia in hospitalized patients

10.1001/jamanetworkopen.2020.30913 · 2021 · External reference

Unresolved reference

External reference

The Ethics of creating and using human-animal chimeras

10.1093/ilar/ilaa002 · 2019 · External reference

Fullerene derivatives as lung cancer cell inhibitors: investigation of potential descriptors using QSAR approaches

10.2147/ijn.s243463 · 2020 · External reference

10.1016/j.chemosphere.2021.130681

10.1016/j.chemosphere.2021.130681 · External reference

10.1016/j.jmgm.2017.03.020

10.1016/j.jmgm.2017.03.020 · External reference

10.1080/07391102.2016.1206487

10.1080/07391102.2016.1206487 · External reference

Combined 4D-QSAR and target-based approaches for the determination of bioactive Isatin derivatives

10.1080/1062936x.2021.1971760 · 2021 · External reference

10.1002/jcc.26154

10.1002/jcc.26154 · External reference

10.1021/jm4004285

10.1021/jm4004285 · External reference

Advantages and limitations of classic and 3D QSAR approaches in nano-QSAR studies based on biological activity of fullerene derivatives

10.1007/s11051-016-3564-1 · 2016 · External reference

4D-QSAR: perspectives in drug design

10.3390/molecules15053281 · 2010 · External reference

QSAR Use in REACH analyses of alternatives to predict human health and environmental toxicity of alternative chemical substances

10.1002/ieam.4264 · 2020 · External reference

In silico Prediction and insights into the structural basis of drug induced nephrotoxicity

2022 · External reference